Sakar Healthcare Ltd

NSE: SAKAR · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹1,023.90
Market cap: ₹2,278 Cr
Revenue (annual): ₹251.7 Cr
Net profit (annual): ₹30.48 Cr
P/E (TTM): 63.1×Sector 47.4×
Promoter holding: 52.52%-0.34% QoQ
FII holding: 12.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Other Announcement 3 Financial Results 3 Results Update 2 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Regulatory Approval 1 Price Movement Clarification 1 Partnership 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Jul 2026 20:14 IST NSE

Results Update

Sakar Healthcare Results Update

Sakar Healthcare announced Q1FY27 results, reporting 38% YoY revenue growth. Strong operating performance was driven by oncology product contracts and global dossier approvals.

Read the filing ↗

13 May 2026 09:13 IST NSE

Results Update

Sakar Healthcare Results Update

Sakar Healthcare reported FY26 revenue of ₹251.74 Crore, a 42% YoY increase. EBITDA rose 39% to ₹68.89 Crore, driven by strong oncology product performance.

Value: ₹251.7 Cr

Read the filing ↗